Want to see ABOS full AI Analyst Report?
Acumen Pharmaceuticals (ABOS) Ownership - Who Owns Acumen Pharmaceuticals?
Acumen Pharmaceuticals (ABOS) Ownership Overview
- 32.71% Insiders
- 6.04% Mutual Funds
- 0.08% Other Institutional Investors
- 5.81% ETFs
- 55.37% Public Companies and Individual Investors
The ownership structure of Acumen Pharmaceuticals (ABOS) stock is a mix of institutional, retail, and individual investors. Approximately 11.92% of the company’s stock is owned by Institutional Investors, 32.71% is owned by Insiders, and 55.37% is owned by Public Companies and Individual Investors.
The ownership structure of Acumen Pharmaceuticals (ABOS) stock is a mix of institutional, retail, and individual investors. Approximately 6.11% of the company’s stock is owned by Institutional Investors, 32.71% is owned by Insiders, and 5.81% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Jun 16, 2026 | Derrell Porter | $75,065 | |
| Jun 09, 2026 | Nathan B Fountain | $14,272 |
Recent Hedge Fund Trading Activity
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Ra Capital Management, Llc | 21,040,969 | Insider | 29.09% | 4,418,603 |
| Peter Kolchinsky | 20,992,669 | Institution | 29.02% | 4,408,460 |
| Vanguard | 2,099,843 | Institution | 2.90% | 440,967 |
| Ishares | 1,717,039 | Institution | 2.37% | 360,578 |
| Vanguard Index Funds | 1,631,833 | Institution | 2.26% | 342,685 |
| Daniel Joseph Oconnell | 881,275 | Insider | 1.22% | 185,068 |
| Franklin Strategic Series | 826,400 | Institution | 1.14% | 173,544 |
| Fidelity Salem Street Trust | 579,605 | Institution | 0.80% | 121,717 |
| Fidelity Concord Street Trust | 416,182 | Institution | 0.58% | 87,398 |
| Vanguard Scottsdale Funds | 319,561 | Institution | 0.44% | 67,108 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 1,631,833 | Institution | 2.26% | 342,685 |
| Franklin Strategic Series | 826,400 | Institution | 1.14% | 173,544 |
| Fidelity Salem Street Trust | 579,605 | Institution | 0.80% | 121,717 |
| Fidelity Concord Street Trust | 416,182 | Institution | 0.58% | 87,398 |
| Vanguard Scottsdale Funds | 319,561 | Institution | 0.44% | 67,108 |
| Bridgeway Funds, Inc. | 162,871 | Institution | 0.23% | 34,203 |
| Schwab Capital Trust | 115,088 | Institution | 0.16% | 24,168 |
| Goldman Sachs Trust | 84,445 | Institution | 0.12% | 17,733 |
| Tiaa-cref Funds | 63,355 | Institution | 0.09% | 13,305 |
| Dfa Investment Dimensions Group Inc | 50,202 | Institution | 0.07% | 10,542 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 1,262,692 | Institution | 1.75% | 2,803,176 |
| iShares | 1,143,668 | Institution | 1.58% | 2,619,000 |
| Vanguard | 513,511 | Institution | 0.71% | 1,139,994 |
| iShares | 427,467 | Institution | 0.59% | 978,899 |
| Vanguard | 273,518 | Institution | 0.38% | 607,210 |
| iShares | 144,013 | Institution | 0.20% | 329,790 |
| DFA | 122,212 | Institution | 0.17% | 279,865 |
| Bridgeway | 85,505 | Institution | 0.12% | 195,806 |
| Vanguard | 43,424 | Institution | 0.06% | 96,401 |
| Avantis | 38,824 | Institution | 0.05% | 88,907 |
FAQ
Who Owns Acumen Pharmaceuticals (ABOS)?
According to the latest TipRanks data, approximately 0.08% of the company's stock is held by institutional investors, 32.71% is held by insiders, and 55.37% is held by retail investors.
What percentage of Acumen Pharmaceuticals (ABOS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.08% of Acumen Pharmaceuticals (ABOS) stock is held by institutional investors.
What percentage of Acumen Pharmaceuticals (ABOS) stock is held by retail investors?
According to the latest TipRanks data, approximately 55.37% of Acumen Pharmaceuticals (ABOS) stock is held by retail investors.
Who owns the most shares of Acumen Pharmaceuticals (ABOS)?
Ra Capital Management, Llc owns the most shares of Acumen Pharmaceuticals (ABOS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.